Results 181 to 190 of about 9,097 (242)

MonoHER selectively enhances the radiotherapy response in p53 wild-type breast cancer via stabilization of p53. [PDF]

Clin Transl Radiat Oncol
Li C, Li X, Biemans R, Zhang M, Dubois LJ.   +4 more
europepmc   +1 more source

The MTH1 inhibitor TH287 sensitized Castration-Resistant Prostate Cancer cells to ionizing radiation therapy. [PDF]

Int Urol Nephrol
Tian Y, Hu X, Mao Y, Tang Z, Hu M.
europepmc   +1 more source

Successful Multimodal Therapeutic Approach for CD30-positive Folliculotropic Mycosis Fungoides. [PDF]

J Dtsch Dermatol Ges
Blomen CL, Hansen-Abeck I, Baehr A, Schneider SW, Gebhardt C, Booken N.   +5 more
europepmc   +1 more source

Non-surgical breast-conserving treatment using Kochi oxydol-radiation therapy for unresectable carcinomas II for patients with stage 0 to IIIC breast cancer. [PDF]

Oncol Lett
Hori A, Shimbo T, Ikenaga J, Itami T, Mukai M, Kobata K, Ogawa T, Kihara A, Nakata M, Yoshino Y, Takeno S, Nawa K, Yoshioka H, Nihei K, Akiyama H, Yoshida K, Kimura K, Iwamoto M.   +17 more
europepmc   +1 more source

Radiosensitization

, 2018
Weber, K. J., Witte, S., Rothkamm, K., Rave-Fraenk, Margret, Virsik-Koepp, Patricia, Kupper, J. H., Rudat, V., Lobrich, M.   +7 more
openaire   +1 more source

RRx-001, a Novel Dinitroazetidine Radiosensitizer [PDF]

Investigational New Drugs, 2016
The 'holy grail' in radiation oncology is to improve the outcome of radiation therapy (RT) with a radiosensitizer-a systemic chemical/biochemical agent that additively or synergistically sensitizes tumor cells to radiation in the absence of significant ...
Jan Scicinski, Bryan Oronsky, Pedro Cabrales   +2 more
exaly   +2 more sources

Development of a Novel Enzyme-Targeting Radiosensitizer (New KORTUC) Using a Gelatin-Based Hydrogel Instead of a Sodium Hyaluronate

Cancers, 2016
We recently developed Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas (KORTUC) as a strategy to increase intratumoral oxygen concentrations and degrade antioxidant enzymes such as peroxidase and catalase.
Yasuhiro Ogawa, Akihito Nishioka, Shiho Morita-Tokuhiro   +2 more
exaly   +2 more sources

5-(N-Trifluoromethylcarboxy)Aminouracil as a Potential DNA Radiosensitizer and Its Radiochemical Conversion Into N-Uracil-5-Yloxamic Acid

International Journal of Molecular Sciences, 2020
Hypoxia—a hallmark of solid tumors—dramatically impairs radiotherapy, one of the most common anticancer modalities. The adverse effect of the low-oxygen state can be eliminated by the concomitant use of a hypoxic cell radiosensitizer.
Paulina Spisz, Artur Sikorski, Samanta Makurat   +2 more
exaly   +2 more sources